| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.11B | +245.9% |
| R&D Expense | $79.2M | +15.6% |
| SG&A Expense | $227.9M | +21.8% |
| Operating Income | -$369.8M | -18.2% |
| Interest Expense | $32.7M | +150.9% |
| Pre-tax Income | -$221.5M | -161.0% |
| Income Tax | -$66K | +95.4% |
| Net Income | -$221.4M | -186.1% |
| EPS (Basic) | -$12.01 | -73.3% |
| EPS (Diluted) | -$12.01 | -73.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.5M | -83.4% |
| Accounts Receivable | $15.5M | +87.5% |
| Current Assets | $220.1M | -29.6% |
| Total Assets | $246.1M | -44.9% |
| Current Liabilities | $162.4M | -0.7% |
| Long-term Debt | $278.0M | +64.9% |
| Total Liabilities | $502.0M | -17.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$311.4M | -64.4% |
| Investing Cash Flow | -$8.5M | +74.8% |
| Financing Cash Flow | $173.2M | -55.0% |
| Stockholders' Equity |
| -$255.9M |
| -58.6% |